Joint venture forms new mass spectrometry company
AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
“This integrated company will be able to shape the future of mass spectrometry in ways far greater than what we have already achieved,” said Laura Lauman, the company’s president, in a statement. According to Lauman, bringing the former joint venture together will enable the company to “keep pace with the dynamic needs of the life science industry.”
The company provides instrumentation, software and services used in a number of life science applications, including drug discovery and development, disease studies and food and environmental safety. These include integrated LC–MS–MS platforms for small molecule analysis, contaminant identification and biomarker validation, as well as MALDI TOF/TOF systems for protein biomarker discovery.
For more information about the company go to www.absciex.com
Daisy Unsihuay Vila Wins Darlene Solomon Award for Clinical MS Research
March 17th 2025Daisy Unsihuay Vila of Henry Ford Health (Detroit, Michigan) was awarded the 2025 Agilent Technologies and Females in Mass Spectrometry’s (FeMS’s) Darlene Solomon Award for her research focused on improving mass spectrometry (MS) techniques in clinical settings, particularly for drug monitoring and toxicology analysis.
